- Boxer Ryan Garcia refuted allegations of using performance-enhancing drugs (PEDs) following a positive test for Ostarine, a banned substance, ahead of his fight against Devin Haney.
- Garcia tested positive for Ostarine on the day before and the day of the fight, according to a Voluntary Anti-Doping Association letter.
- In a video posted on social media, Garcia denied using steroids, claiming he doesn’t know where to get them and barely takes supplements. He also questioned the timing of the reports and the decision to allow him to fight despite the positive test results.
Newsypeople- Ryan Garcia, a prominent boxer, has recently faced allegations of using a performance-enhancing substance, specifically Ostarine, following a positive test report before his victory over Devin Haney. Despite the evidence suggesting otherwise, Garcia has categorically denied any wrongdoing, asserting that he does not cheat and has never taken steroids.
He has also questioned why the positive test results were only revealed after the fight, implying a lack of transparency or fairness in the process. The Voluntary Anti-Doping Association (VADA), which conducted the drug testing for the fight, confirmed the adverse findings from Garcia’s samples taken the day before and the day of the fight.
Ostarine, a Selective Androgen Receptor Modulator (SARM), is banned by the World Anti-Doping Agency due to its potential to stimulate muscle growth. Garcia’s promoters, Golden Boy Promotions, have expressed their belief in Garcia’s innocence and stated they would investigate how the positive finding came to be.
Devin Haney, Garcia opponent, has expressed disappointment and frustration over the situation, stating that Garcia’s actions have tarnished the sport of boxing. Haney believes that Garcia’s behavior has disrespected both the fans and the sport itself by engaging in what he perceives as cheating.
Garcia’s victory in the fight, which saw him knock down Haney three times, could potentially be overturned if the positive drug test is confirmed. However, Garcia has 10 days to request that his B-sample be tested, which could potentially clear his name if it returns negative.
This incident has sparked widespread debate within the boxing community and beyond, with many questioning the integrity of the sport and the fairness of the testing procedures. Garcia’s denial and the subsequent reactions from both his camp and critics highlight the complex dynamics surrounding doping allegations in professional sports.
What Is Ostarine And How Does It Work To Stimulate Muscle Growth?
Ostarine, also known as Enobosarm, is a Selective Androgen Receptor Modulator (SARM). SARMs are a class of drugs designed to have the therapeutic benefits of anabolic-androgenic steroids (AAS), such as increased muscle mass and bone density, but with fewer side effects. Unlike traditional anabolic steroids, SARMs are designed to selectively target the androgen receptors in muscle and bone tissues, thereby stimulating anabolic effects in these areas without the same level of impact on other tissues like the prostate and liver.
The mechanism of action for SARMs like Ostarine involves binding to the androgen receptor (AR) in muscle and bone cells. Once bound, the SARM-AR complex can modulate gene expression, leading to increased protein synthesis and muscle growth. This process is similar to how testosterone works in the body, but SARMs are more selective, meaning they can activate the AR in certain tissues while having minimal effect in others. This selectivity is crucial for minimizing side effects associated with anabolic steroid use, such as prostate enlargement and liver damage.
Research has shown that SARMs can significantly improve muscle strength and body composition, as well as prevent bone loss in animal models. For example, studies have demonstrated that SARM treatment can increase muscle mass and strength in castrated male rats, indicating its potential for muscle-building effects in humans. Additionally, SARMs have been found to reduce body fat and prevent bone loss in ovariectomized rats, suggesting their potential benefits for bone health and body composition.
However, it’s important to note that while SARMs show promise for treating conditions like muscle wasting and osteoporosis, their use in humans is still under investigation. Clinical trials have reported modest increases in fat-free mass, but more research is needed to fully understand their efficacy and safety profile. The potential for SARMs to provide targeted therapeutic benefits without the adverse effects of traditional anabolic steroids makes them an exciting area of research, but their use should be approached with caution until more is known about their long-term effects and regulatory approval status.
